Standout Papers

Nilotinib versus Imatinib for Newly Diagnosed Chronic My... 1999 2026 2008 2017 1.1k
  1. Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia (2010)
    Giuseppe Saglio, Dong‐Wook Kim et al. New England Journal of Medicine
  2. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program (2003)
    J Gäbert, Emmanuel Beillard et al. Leukemia
  3. Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet (2009)
    Michele Baccarani, Jörge E. Cortes et al. Journal of Clinical Oncology
  4. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease (1999)
    Jacques J. M. van Dongen, EA Macintyre et al. Leukemia
  5. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program (2003)
    Emmanuel Beillard, Niels Pallisgaard et al. Leukemia
  6. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial (2016)
    Jörge E. Cortes, Giuseppe Saglio et al. Journal of Clinical Oncology
  7. Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial (2016)
    Andreas Hochhaus, Giuseppe Saglio et al. Leukemia

Immediate Impact

22 by Nobel laureates 21 from Science/Nature 78 standout
Sub-graph 1 of 19

Citing Papers

A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
3 intermediate papers

Works of Giuseppe Saglio being referenced

A molecular study of a family with Greek hereditary persistence of fetal hemoglobin and beta-thalassemia.
1984
Molecular comparison of delta beta-thalassemia and hereditary persistence of fetal hemoglobin DNAs: evidence of a regulatory area?
1982
and 2 more

Author Peers

Author Last Decade Papers Cites
Giuseppe Saglio 18032 13149 6880 643 24.4k
Michele Baccarani 19737 14203 7958 704 28.3k
Jerald P. Radich 16407 9835 5356 393 21.5k
John M. Goldman 21809 13997 8428 486 29.2k
Michael W. Deininger 15874 12145 7397 397 20.6k
Elias Jabbour 17507 9130 3806 1.1k 24.5k
Stefan Faderl 16625 10640 3420 567 26.4k
Srđan Verstovšek 18254 18322 8353 1.1k 29.2k
François Guilhot 14255 10326 6618 347 18.0k
Mario Cazzola 17225 14794 4281 421 24.6k
Deborah A. Thomas 12009 10024 2589 448 22.7k

All Works

Loading papers...

Rankless by CCL
2026